#

Small caps

: 1083
Krispy Kreme shares are 40% off their price a year ago / Photo: krispykreme.com
Small Caps·
Krispy Kreme shares shoot up almost 30% on 4Q/FY earnings
The dynamics of small caps in emerging markets reflect domestic economic processes to a greater extent, while global trends tend to drive the performance of large companies / Photo: Shutterstock.com
Small Caps·
Where to find outstripping returns in EM small caps in 2026
Dutch Bros shares trade 45% below their record / Photo: Facebook/Dutch Bros
Small Caps·
Motley Fool analyst likes growing U.S. coffee chain Dutch Bros on dip
VolitionRx shares soar on positive news / Photo: Facebook/VolitionRx
Small Caps·
Cancer blood test maker VolitionRX soars 25% in a day on reported commercial progress
Wall Street sees 45% upside in shares of Brazilian fintech PicPay / Photo: Facebook / PicPayBrasil
Small Caps·
BofA is latest to initiate on Brazilian digital bank PicPay at 'buy'
Vir Biotechnology shares jumped on the announcement of a new partnership and other news / Photo: X / Vir Biotech
Small Caps·
'Seminal moment': Biotech Vir sees shares jump over 25% amid flurry of announcements
Latvian natural cosmetics manufacturer Madara exports its products to more than 35 countries / Photo: Facebook / Madara
Small Caps·
Freedom24-Lithuania head shares Baltic small-cap stocks and sectors with 2026 upside
Shares of York Space Systems have been almost unanimously rated buy by Wall Street analysts / Photo: York Space Systems
Small Caps·
Eight analysts initiate on space stock York with 'buy' following recent IPO
Arcellx shares have soared on news of its acquisition / Photo: X / Nasdaq Exchange
Small Caps·
Cancer drugmaker Arcellx explodes 77% in a day as Gilead will acquire it
EV maker Lucid is preparing to release a mass-market model, but its too early to buy the stock, according to the Motley Fool / Photo: Lucid
Small Caps·
Motley Fool analyst warns against temptation to buy EV maker Lucid on the dip
HIMS is looking to bounce back after a lawsuit from Novo Nordisk over its compounded GLP-1 drugs that sank its stock / Photo: Hims & Hers
Small Caps·
Hims & Hers to buy Australian peer Eucalyptus amid GLP-1 regulatory, legal pressure
Analysts believe Pelatons stock could rise as much as 60% from current levels, according to MarketWatch data / Photo: Facebook / Peloton
Small Caps·
Insider Monkey spotlights 12 best penny stocks set to skyrocket
Load more